Literature DB >> 34241810

Plasma Kallikrein Contributes to Intracerebral Hemorrhage and Hypertension in Stroke-Prone Spontaneously Hypertensive Rats.

Jian Guan1, Allen C Clermont2, Loc-Duyen Pham1, Tuna Ustunkaya1, Alexey S Revenko3, A Robert MacLeod3, Edward P Feener2, Fabrício Simão4.   

Abstract

Plasma kallikrein (PKa) has been implicated in contributing to hemorrhage following thrombolytic therapy; however, its role in spontaneous intracerebral hemorrhage is currently not available. This report investigates the role of PKa on hemorrhage and hypertension in stroke-prone spontaneously hypertensive rats (SHRSP). SHRSP were fed with a high salt-containing stroke-prone diet to increase blood pressure and induce intracerebral hemorrhage. The roles of PKa on blood pressure, hemorrhage, and survival in SHRSP were examined in rats receiving a PKa inhibitor or plasma prekallikrein antisense oligonucleotide (PK ASO) compared with rats receiving control ASO. Effects on PKa on the proteolytic cleavage of atrial natriuretic peptide (ANP) were analyzed by tandem mass spectrometry. We show that SHRSP on high-salt diet displayed increased levels of PKa activity compared with control rats. Cleaved kininogen was increased in plasma during stroke compared to SHRSP without stroke. Systemic administration of a PKa inhibitor or PK ASO to SHRSP reduced hemorrhage and blood pressure, and improved neurological function and survival compared with SHRSP receiving control ASO. Since PKa inhibition was associated with reduced blood pressure in hypertensive rats, we investigated the effects of PKa on the cleavage of ANP. Incubation of PKa with ANP resulted in the generation fragment ANP5-28, which displayed reduced effects on blood pressure lowering compared with full length ANP. PKa contributes to increased blood pressure in SHRSP, which is associated with hemorrhage and reduced survival. PKa-mediated cleavage of ANP reduces its blood pressure lowering effects and thereby may contribute to hypertension-induced intracerebral hemorrhage.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Atrial natriuretic peptide; Hypertension; Intracerebral hemorrhage; Plasma kallikrein; Stroke

Mesh:

Substances:

Year:  2021        PMID: 34241810      PMCID: PMC8742844          DOI: 10.1007/s12975-021-00929-x

Source DB:  PubMed          Journal:  Transl Stroke Res        ISSN: 1868-4483            Impact factor:   6.829


  55 in total

1.  Predisposing factors to enlargement of spontaneous intracerebral hematoma.

Authors:  S Kazui; K Minematsu; H Yamamoto; T Sawada; T Yamaguchi
Journal:  Stroke       Date:  1997-12       Impact factor: 7.914

2.  Factors influencing admission blood pressure levels in patients with acute stroke.

Authors:  B Carlberg; K Asplund; E Hägg
Journal:  Stroke       Date:  1991-04       Impact factor: 7.914

3.  Cerebral small vessel endothelial structural changes predate hypertension in stroke-prone spontaneously hypertensive rats: a blinded, controlled immunohistochemical study of 5- to 21-week-old rats.

Authors:  E L Bailey; J M Wardlaw; D Graham; A F Dominiczak; C L M Sudlow; C Smith
Journal:  Neuropathol Appl Neurobiol       Date:  2011-12       Impact factor: 8.090

4.  Proteomic identification of novel plasma kallikrein substrates in the astrocyte secretome.

Authors:  Jia Liu; Ben-Bo Gao; Edward P Feener
Journal:  Transl Stroke Res       Date:  2010-08-28       Impact factor: 6.829

Review 5.  The plasma kallikrein-kinin system: its evolution from contact activation.

Authors:  A H Schmaier; K R McCrae
Journal:  J Thromb Haemost       Date:  2007-09-19       Impact factor: 5.824

6.  Atrial natriuretic factor: a hormone produced by the heart.

Authors:  A J de Bold
Journal:  Science       Date:  1985-11-15       Impact factor: 47.728

7.  Hemorrhagic stroke development in spontaneously hypertensive rats fed a North American, Japanese-style diet.

Authors:  J S Smeda
Journal:  Stroke       Date:  1989-09       Impact factor: 7.914

8.  Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension.

Authors:  S W John; J H Krege; P M Oliver; J R Hagaman; J B Hodgin; S C Pang; T G Flynn; O Smithies
Journal:  Science       Date:  1995-02-03       Impact factor: 47.728

9.  Plasma kallikrein mediates angiotensin II type 1 receptor-stimulated retinal vascular permeability.

Authors:  Joanna A Phipps; Allen C Clermont; Sukanto Sinha; Tamie J Chilcote; Sven-Erik Bursell; Edward P Feener
Journal:  Hypertension       Date:  2009-01-05       Impact factor: 10.190

10.  Antihypertensive effect of a 5-day infusion of atrial natriuretic factor in humans.

Authors:  W M Janssen; D de Zeeuw; G K van der Hem; P E de Jong
Journal:  Hypertension       Date:  1989-06       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.